We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Fusion Antibodies Plc | LSE:FAB | London | Ordinary Share | GB00BDQZGK16 | ORD 4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 6.65 | 6.30 | 7.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 6.65 | 6.65 | 6.65 | 143,838 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 1.14M | -2.23M | -0.0233 | -2.85 | 6.34M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 02/6/2025 | 07:00 | UK RNS | Fusion Antibodies PLC Total Voting Rights |
| 22/5/2025 | 22:51 | ALNC |  TRADING UPDATES: Poolbeg upsizes offer; Glenveagh backs outlook |
| 22/5/2025 | 14:33 | UK RNS | Fusion Antibodies PLC Update on U.S. Patent for OptiMAL® |
| 08/5/2025 | 07:00 | UK RNS | Fusion Antibodies PLC Investor presentation |
| 07/5/2025 | 07:00 | UK RNS | Fusion Antibodies PLC Issue of shares to non-executive directors |
| 06/5/2025 | 10:53 | UK RNS | Fusion Antibodies PLC Director/PDMR Shareholding |
| 06/5/2025 | 10:38 | UK RNS | Fusion Antibodies PLC Holding(s) in Company |
| 06/5/2025 | 07:00 | UK RNS | Fusion Antibodies PLC Trading update |
| 30/4/2025 | 17:00 | UK RNS | Fusion Antibodies PLC Total Voting Rights |
| 24/4/2025 | 07:00 | UK RNS | Fusion Antibodies PLC Approval of grant funding |
1 Year Fusion Antibodies Chart |
Intraday Fusion Antibodies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
